A provider will discuss the results with a patient before moving forward with pellet therapy
We have access to the full spectrum because our physicians stay current on peptide research and work with multiple compounding pharmacies
This creates clean, easy-to-read measurements on a standard U-100 insulin syringe
Another, more indirect method of modulating immune cells is to block cytokines, exemplified by (halted) clinical exploration of an antibody blockade of IL-6 in gMG by use of the IL-6 receptor targeting IgG2 satrilizumab (Enspryng) [392,393,394]
At the root of the issue was a notion of fair play that had been badly undermined
Because all of these organizations use WADA and USADA banned substances list, and BPC-157 is currently classified as Not FDA approved Classified as experimental Peptide with potential performance/recovery effects It will be interesting to see how this changes if/when it gets changed to Category 1, likely later this year by the FDA